Preventive and inhibitive effects of Yiwei Xiaoyu granules on the development and progression of spasmolytic polypeptide-expressing metaplasia lesions

doi:10.4251/wjgo.v13.i11.1741

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4045)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-10) series.

Item

Count

PDF

306

WORD

130

HTML

2454

Figures (1-10)

185

Sum=3075

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

361

Download

609

Sum=970

Nov 15, 2021 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Nov 15, 2021; 13(11): 1741-1754
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1741

Full Size Figure Download Figure

Figure 4 Fluorescence in situ hybridization analysis of microRNA-7 expression in spasmolytic polypeptide-expressing metaplasia and normal controls. The expression of microRNA-7 was downregulated in spasmolytic polypeptide-expressing metaplasia compared to in normal controls. SPEM: Spasmolytic polypeptide-expressing metaplasia; Mir-7: MicroRNA-7.

Citation: Chen WQ, Tian FL, Zhang JW, Yang XJ, Li YP. Preventive and inhibitive effects of Yiwei Xiaoyu granules on the development and progression of spasmolytic polypeptide-expressing metaplasia lesions. World J Gastrointest Oncol 2021; 13(11): 1741-1754
URL: https://www.wjgnet.com/1948-5204/full/v13/i11/1741.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i11.1741